Correlation between the presence of high-risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer

Clinical Microbiology and Infection

Volumn 16, Issue 3, 2010, Pages 262-266

  Darnel, A D ^a,b   Wang, D ^c   Ghabreau, L ^d   Yasmeen, A ^a,b   Sami, S ^a   Akil, N ^d   Al Moustafa, A E ^a,b,d,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^e Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

Cervical cancer; High risk HPV; Id genes; Syrian women

Indexed keywords

BINDING PROTEIN; INHIBITORS OF DIFFERENTIATION AND DNA BINDING; PROTEIN E6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYRIAN ARAB REPUBLIC; UTERINE CERVIX CANCER; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 76749112109     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02774.x     Document Type: Article

References (26)

1. de Sanjosé S, Diaz M, Castellsagué X. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459.
2. Smith JS, Lindsay L, Hoots B. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121:621-632.
3. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003, 9:6469-6475.
4. Graflund M, Sorbe B, Sigurdardottir S, Karlsson M. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas. Int J Gynecol Cancer 2004, 14:896-902.
5. Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol 2004, 17:1314-1322.
6. Vousden KH. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 1995, 6:109-116.
7. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
8. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937.
9. Dyson N, Guida P, Munger K, Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 1992, 66:6893-6902.
10. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003, 3:525-530.
11. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004, 10:387-392.
12. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 2001, 61:5703-5706.
13. Wilson JW, Deed RW, Inoue T. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 2001, 61:8803-8810.
14. Desprez PY, Sumida T, Coppe JP. Helix-loop-helix proteins in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003, 8:225-239.
15. Lee KT, Lee YW, Lee JK. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. Br J Cancer 2004, 90:1198-1203.
16. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 2004, 10:2044-2051.
17. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, Al Moustafa AE. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 2007, 6:2038-2042.
18. Kuefer R, Hofer MD, Gschwend JE, Rubin MA. Tissue microarrays. High-throughput procedures to verify potential biomarkers. Urologe A 2004, 43:659-666.
19. Muñoz N, Bosch FX, Castellsagué X. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004, 111:278-285.
20. Castellsagué X, Díaz M, de Sanjosé S. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006, 98:303-315.
21. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002, 23:429-432.
22. Inal MM, Köse S, Yildirim Y. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007, 17:1266-1270.
23. Schwartz SM, Daling JR, Shera KA. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001, 19:1906-1915.
24. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
25. Akil MN, Darnel A, Yasmeen A, Kassab A, Al Moustafa A-E. Association of Id-1 expression with high-risk human papillomaviruses infection in breast cancer in Syrian woman: a tissue microarray study. Br J Cancer 2008, 99:404-407.
26. Ferenczy A, Franco EL. Prophylactic human papillomavirus vaccines: potential for sea change. Expert Rev Vaccines 2007, 6:511-525.